GPP78 (CAY10618) is a potent nicotinamide phosphoribosyltransferase (Nampt) inhibitor with anticancer and anti-inflammatory activities; it induces autophagy-mediated cytotoxicity in neuroblastoma SH-SY5Y cells; it inhibits the growth of various cancer cell lines derived from leukemia, lung, central nervous system (CNS), colon, melanoma, ovarian, renal, and prostate cancers; it reduces the severity of spinal cord injury in mice, significantly ameliorating SCI-induced demyelination and functional deficits.